RAD BioMed
Investor Israel Est. 2011
Team
3
Confidence
57/100
News
10
articles
About
RAD Biomed is an Israel-based private incubator that invests in early-stage biomedical and Hi-Tech start-ups. RAD Biomed invests in exciting new solutions at the earliest stages, providing a full set of operational and professional services, mentorship and industry connections. Rad Biomed was launched by the RAD Group, a group of independent companies that develop, manufacture, and market solutions for diverse segments of the networking and telecommunications industry. The RAD Group has decades of experience in guiding and nurturing start-ups as they grow towards commercial launch, sales growth, and successful exit, with nine Nasdaq IPOs and 10 M&As.
Classification
Tags
bioconvergencebiopharmaceuticalmedical-technologiesmedical-devicesbiotechnologyhealthcare-itdigital-healthcarelife-sciencesheart-failurestrokechildrenartificial-intelligencecommunicationswomen-healthmachine-learningophthalmologytherapeuticscyber-securitycardiology
News (10)
Sep 29, 2025 · www.calcalistech.com
growth-positive
A chance encounter at university led Dr. Eyal Orion to the Zisapel brothers’ RAD Biomed incubator, setting him on a path to found five medical device companies, including one sold for $100 million. This month, he achieved a second exit with the $497 million sale of Vectorious, developer of a heart failure–detecting sensor.
Acquired-by
Aug 18, 2020 · www.prnewswire.com
growth-positive
Global Pharma Company Exercises Rights for Exclusive Use of Everads Drug Delivery Technology in Specific Retinal Targets
Partners
Jul 21, 2020 · www.calcalistech.com
growth-positive
Belkin Laser announces $12.2 million raised in series B funding
Investment
Jun 7, 2020 · www.prnewswire.com
growth-positive
VasQ™ External Support Awarded Breakthrough Device Designation by the FDA
Customers
Mar 25, 2020 · www.prnewswire.com
growth-positive
Zsquare Named A Silver Winner of the 2020 Edison Awards
CustomersPartners
Mar 12, 2020 · www.youtube.com
Vectorious' V-LAP arrives in Israel: Live interview with Dr. Leor Perl
Mar 12, 2020 · www.prnewswire.com
growth-positive
Everads Therapy Enters Into Option Agreement With Global Pharma Company to License Everads' Suprachoroidal Delivery System for Retinal Disease Therapies
Partners
Feb 4, 2020 · www.prnewswire.com
growth-positive
Enrollment of the VasQ™ External Support US Pivotal Study Now Complete
Customers
Oct 21, 2019 · www.prnewswire.com
growth-positive
Perflow Medical Receives CE Mark Approval of Novel Cascade™ Agile
CustomersPartners
Mar 5, 2019 · www.prnewswire.com
growth-positive
VGS Completes Enrollment of VEST U.S. Pivotal Trial for the Evaluation of Its Venous External Support Technology for Coronary Bypass Surgery
Customers
Locations
Raoul Wallenberg St 24, Tel Aviv-Yafo, Israel
Links
Website
LinkedIn
Twitter
Facebook
Admin
Last Update
Sep 25, 2024
Verified by
Natalia Golczar
Missing
funding stage, product stage, sector, number of employees, business model, tag line, video or image, funding rounds, markets
Team (3)
Yehuda Zisapel
Co-founder
Founder
Nava Zisapel
Co-founder & Chairperson
Founder
Carmi Zisapel
Business Development Manager
Internal
Created
2016-01-06T00:00:00.000Z
Last editor
Vered Waxman (vered.waxman@sncentral.org)
Status
Active
Recent activity
Matan Eblagon · Manual · 2024-09-25 04:35:35.000000
Ortal Wein · Manual · 2023-03-20 12:16:47.000000
Ortal Wein · Manual · 2023-12-28 15:05:03.000000
Yanina Wainscheinker · Manual · 2023-02-21 13:30:58.000000
Ortal Wein · Manual · 2023-12-28 15:05:03.000000
Matan Eblagon · Manual · 2024-09-25 04:35:34.000000
Yanina Wainscheinker · Manual · 2023-02-21 13:30:58.000000
Matan Eblagon · Manual · 2024-09-25 04:35:34.000000
Matan Eblagon · Manual · 2024-09-25 04:49:00.000000
Matan Eblagon · Manual · 2024-09-25 04:48:59.000000